Medicine for Osteoarthritis Pain Market Report

Global and China Medicine for Osteoarthritis Pain Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 25, 2022
  • PAGES：164
  • REPORT CODE：GMM1407533
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Medicine for Osteoarthritis Pain industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Tide Pharmaceutical

    • GlaxoSmithKline

    • TEVA

    • Iroko Pharmaceuticals

    • Horizon Pharma

    • Abbott

    • Mylan

    • Pfizer

    • Hengrui Pharmaceutical

    • Eli Lilly

    • Abiogen Pharma

    • Bayer

    • Johnson & Johnson

    • Almatica Pharma

    • Sanofi

    • Novartis

    • Astellas Pharma

    • Daiichi Sankyo

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Injection

    • External

    Application:

    • Medical Care

    • Personal Care

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Medicine for Osteoarthritis Pain Industry Overview

      • 1.1.1 Medicine for Osteoarthritis Pain Market Scope and Market Segments

      • 1.1.2 Medicine for Osteoarthritis Pain Industry Characteristics

      • 1.1.3 Global and China Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Medicine for Osteoarthritis Pain Production Value and Growth Rate (2017-2028)

    • 1.2 Global Medicine for Osteoarthritis Pain Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Injection

      • 1.2.3 External

    • 1.3 Global Medicine for Osteoarthritis Pain Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Medical Care

      • 1.3.2 Personal Care

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Medicine for Osteoarthritis Pain Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Medicine for Osteoarthritis Pain Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Medicine for Osteoarthritis Pain Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Medicine for Osteoarthritis Pain Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Medicine for Osteoarthritis Pain Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Medicine for Osteoarthritis Pain Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Medicine for Osteoarthritis Pain Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Medicine for Osteoarthritis Pain Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Medicine for Osteoarthritis Pain Industry Porter's Five Forces Model Analysis

      • 2.2.3 Medicine for Osteoarthritis Pain Industry PEST Analysis

    • 2.3 Medicine for Osteoarthritis Pain Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Medicine for Osteoarthritis Pain Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Medicine for Osteoarthritis Pain Industry

    Chapter 3 Global and China Medicine for Osteoarthritis Pain Market, by Manufacturer

    • 3.1 Global and China Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Medicine for Osteoarthritis Pain Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Medicine for Osteoarthritis Pain Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Medicine for Osteoarthritis Pain Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Medicine for Osteoarthritis Pain Market Top 3 Players

    Chapter 4 Global and China Medicine for Osteoarthritis Pain Market, by Type (2017-2028)

    • 4.1 Medicine for Osteoarthritis Pain Market Trend, by Type

    • 4.2 Global Medicine for Osteoarthritis Pain Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Medicine for Osteoarthritis Pain Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Medicine for Osteoarthritis Pain Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Medicine for Osteoarthritis Pain Price Trend, by Type (2017-2028)

    • 4.3 China Medicine for Osteoarthritis Pain Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Medicine for Osteoarthritis Pain Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Medicine for Osteoarthritis Pain Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Medicine for Osteoarthritis Pain Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Medicine for Osteoarthritis Pain Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Medicine for Osteoarthritis Pain Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Medicine for Osteoarthritis Pain Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Medicine for Osteoarthritis Pain Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Medicine for Osteoarthritis Pain Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Medicine for Osteoarthritis Pain Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Medicine for Osteoarthritis Pain Market Analysis

    • 7.1 North America Medicine for Osteoarthritis Pain Market, by Type

    • 7.2 North America Medicine for Osteoarthritis Pain Market, by Application

    • 7.3 North America Medicine for Osteoarthritis Pain Market Analysis and Forecast, by Country

      • 7.3.1 United States Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Medicine for Osteoarthritis Pain Market Analysis

    • 8.1 Europe Medicine for Osteoarthritis Pain Market, by Type

    • 8.2 Europe Medicine for Osteoarthritis Pain Market, by Application

    • 8.3 Europe Medicine for Osteoarthritis Pain Market Analysis and Forecast, by Country

      • 8.3.1 Germany Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Medicine for Osteoarthritis Pain Market Analysis

    • 9.1 APAC Medicine for Osteoarthritis Pain Market, by Type

    • 9.2 APAC Medicine for Osteoarthritis Pain Market, by Application

    • 9.3 APAC Medicine for Osteoarthritis Pain Market Analysis and Forecast, by Country

      • 9.3.1 China Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Market Analysis

    • 10.1 Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Market, by Type

    • 10.2 Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Market, by Application

    • 10.3 Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Medicine for Osteoarthritis Pain Company Profiles

      • 11.1 Tide Pharmaceutical

        • 11.1.1 Tide Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.1.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 GlaxoSmithKline

        • 11.2.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 GlaxoSmithKline Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.2.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 TEVA

        • 11.3.1 TEVA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 TEVA Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.3.3 TEVA Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Iroko Pharmaceuticals

        • 11.4.1 Iroko Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.4.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Horizon Pharma

        • 11.5.1 Horizon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Horizon Pharma Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.5.3 Horizon Pharma Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Abbott

        • 11.6.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Abbott Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.6.3 Abbott Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Mylan

        • 11.7.1 Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Mylan Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.7.3 Mylan Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Pfizer

        • 11.8.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Pfizer Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.8.3 Pfizer Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Hengrui Pharmaceutical

        • 11.9.1 Hengrui Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.9.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Eli Lilly

        • 11.10.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Eli Lilly Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.10.3 Eli Lilly Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Abiogen Pharma

        • 11.11.1 Abiogen Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Abiogen Pharma Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.11.3 Abiogen Pharma Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Bayer

        • 11.12.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Bayer Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.12.3 Bayer Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Johnson & Johnson

        • 11.13.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Johnson & Johnson Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.13.3 Johnson & Johnson Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Almatica Pharma

        • 11.14.1 Almatica Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Almatica Pharma Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.14.3 Almatica Pharma Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Sanofi

        • 11.15.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Sanofi Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.15.3 Sanofi Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Novartis

        • 11.16.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Novartis Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.16.3 Novartis Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Astellas Pharma

        • 11.17.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Astellas Pharma Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.17.3 Astellas Pharma Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Daiichi Sankyo

        • 11.18.1 Daiichi Sankyo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Daiichi Sankyo Medicine for Osteoarthritis Pain Product Profiles, Application and Specification

        • 11.18.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Medicine for Osteoarthritis Pain Industry Investment Prospect and Risk Assessment

    • 12.1 Medicine for Osteoarthritis Pain Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Medicine for Osteoarthritis Pain Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Production Value and Growth Rate (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Production Value and Growth Rate (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Market Size and Growth Rate of Injection (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Market Size and Growth Rate of External (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Market Size and Growth Rate of Medical Care (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Market Size and Growth Rate of Personal Care (2017-2028)

    • Figure North America Medicine for Osteoarthritis Pain Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Medicine for Osteoarthritis Pain Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Medicine for Osteoarthritis Pain Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Medicine for Osteoarthritis Pain Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Medicine for Osteoarthritis Pain Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Medicine for Osteoarthritis Pain Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Medicine for Osteoarthritis Pain Market Share, by Manufacturer in 2021

    • Figure Global and China Medicine for Osteoarthritis Pain Market Share, by Manufacturer in 2022

    • Table Global Medicine for Osteoarthritis Pain Sales Volume, by Type (2017-2028)

    • Table Global Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Table Global Medicine for Osteoarthritis Pain Sales Value, by Type (2017-2028)

    • Table Global Medicine for Osteoarthritis Pain Sales Value Share, by Type (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Price Trend, by Type (2017-2028)

    • Table China Medicine for Osteoarthritis Pain Sales Volume, by Type (2017-2028)

    • Table China Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Table China Medicine for Osteoarthritis Pain Sales Value, by Type (2017-2028)

    • Table China Medicine for Osteoarthritis Pain Sales Value Share, by Type (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Price Trend, by Type (2017-2028)

    • Table Global Medicine for Osteoarthritis Pain Sales Volume, by Application (2017-2028)

    • Table Global Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Table Global Medicine for Osteoarthritis Pain Sales Value, by Application (2017-2028)

    • Table Global Medicine for Osteoarthritis Pain Sales Value Share, by Application (2017-2028)

    • Figure Global Medicine for Osteoarthritis Pain Sales Value Share, by Application (2017-2028)

    • Table China Medicine for Osteoarthritis Pain Sales Volume, by Application (2017-2028)

    • Table China Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Table China Medicine for Osteoarthritis Pain Sales Value, by Application (2017-2028)

    • Table China Medicine for Osteoarthritis Pain Sales Value Share, by Application (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Sales Value Share, by Application (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • Figure North America Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Production, Import, Consumption and Export (2017-2022)

    • Table North America Medicine for Osteoarthritis Pain Sales Volume, by Type (2017-2028)

    • Table North America Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Figure North America Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Table North America Medicine for Osteoarthritis Pain Sales Volume, by Application (2017-2028)

    • Table North America Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure North America Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure United States Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure United States Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Canada Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Table Europe Medicine for Osteoarthritis Pain Sales Volume, by Type (2017-2028)

    • Table Europe Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Figure Europe Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Table Europe Medicine for Osteoarthritis Pain Sales Volume, by Application (2017-2028)

    • Table Europe Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure Europe Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure Germany Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure UK Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure UK Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure France Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure France Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Italy Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Spain Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Poland Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Russia Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Table APAC Medicine for Osteoarthritis Pain Sales Volume, by Type (2017-2028)

    • Table APAC Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Figure APAC Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Table APAC Medicine for Osteoarthritis Pain Sales Volume, by Application (2017-2028)

    • Table APAC Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure APAC Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure China Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Japan Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure India Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure India Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Medicine for Osteoarthritis Pain Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Medicine for Osteoarthritis Pain Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Medicine for Osteoarthritis Pain Sales Value and Growth Rate (2017-2028)

    • Table Tide Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tide Pharmaceutical Product Profiles, Application and Specification

    • Table Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TEVA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TEVA Product Profiles, Application and Specification

    • Table TEVA Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Iroko Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Iroko Pharmaceuticals Product Profiles, Application and Specification

    • Table Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Horizon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Horizon Pharma Product Profiles, Application and Specification

    • Table Horizon Pharma Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mylan Product Profiles, Application and Specification

    • Table Mylan Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hengrui Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hengrui Pharmaceutical Product Profiles, Application and Specification

    • Table Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abiogen Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abiogen Pharma Product Profiles, Application and Specification

    • Table Abiogen Pharma Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Almatica Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Almatica Pharma Product Profiles, Application and Specification

    • Table Almatica Pharma Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daiichi Sankyo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daiichi Sankyo Product Profiles, Application and Specification

    • Table Daiichi Sankyo Medicine for Osteoarthritis Pain Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US